Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

P3 Health Partners (PIIIW) Cost of Revenue (2020 - 2025)

P3 Health Partners' Cost of Revenue history spans 6 years, with the latest figure at $335000.0 for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 99.98% year-over-year to $335000.0; the TTM value through Dec 2025 reached $724.0 million, down 62.37%, while the annual FY2025 figure was $918000.0, 99.94% down from the prior year.
  • Cost of Revenue reached $335000.0 in Q4 2025 per PIIIW's latest filing, up from $251000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $1.6 billion in Q4 2024 to a low of -$456.5 million in Q4 2021.
  • Average Cost of Revenue over 5 years is $250.7 million, with a median of $208.1 million recorded in 2021.
  • The largest YoY upside for Cost of Revenue was 115441.3% in 2025 against a maximum downside of 99.98% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at -$456.5 million in 2021, then surged by 330.84% to $1.1 billion in 2022, then crashed by 65.11% to $367.7 million in 2023, then skyrocketed by 323.88% to $1.6 billion in 2024, then plummeted by 99.98% to $335000.0 in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Cost of Revenue are $335000.0 (Q4 2025), $251000.0 (Q3 2025), and $351.3 million (Q2 2025).